RPT-MERCK CHINA: SINOPHARM IS THE SOLE LEGAL AUTHORIZED IMPORTER OF MOLNUPIRAVIR IN CHINA
Merck China: Sinopharm Is The Sole Legal Authorized Importe…
![Reuters logo](/images/reuters.jpg)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.08 HKD | -0.73% |
|
-2.35% | -6.70% |
07-10 | China Accepts Application for Sinopharm Unit's HPV Vaccine | MT |
06-13 | Sinopharm Group Co. Ltd. Declares Final Dividend for the Fiscal Year Ended December 31, 2023, Payable on 13 August 2024 | CI |
RPT-MERCK CHINA: SINOPHARM IS THE SOLE LEGAL AUTHORIZED IMPORTER OF MOLNUPIRAVIR IN CHINA
1st Jan change | Capi. | |
---|---|---|
-6.70% | 7.68B | |
+25.52% | 75.74B | |
-4.70% | 23.24B | |
+17.81% | 8.76B | |
-33.02% | 6.69B | |
+20.70% | 5.58B | |
+4.12% | 4.22B | |
-3.66% | 3.99B | |
+14.24% | 3.39B | |
+10.59% | 3.23B |